Late phase cell cycle proteins in Alzheimer’s disease: a possible target for therapy?

Vladan Bajic, Vladimir B. Bajic, Lada Zivkovic, Thomas Arendt, George Perry, Biljana Spremo-Potparevic

Research output: Contribution to journalArticlepeer-review


Alzheimer’s disease (AD) is represented by neuronal loss and this loss is correlated to a constant state of neuronal instability induced by intrinsic and extrinsic factors. In this paper data is presented regarding the possible roles of late phase cell cycle proteins in normal and affected neurons with the goal that understanding the mechanisms involved in the regulation of these proteins may represent a novel strategy for AD treatment. The results demonstrate a relative differential pattern of expression of certain proteins (APC/C, Mad1 and Mad2, Bub R1, Bub1, CDK 11, cohesin subunit Rad 21 and astrin) in the AD brain versus age matched controls, and it is suggested that targeting these proteins might translate into potential treatments for AD. Although the data presented here is of some interest, the ability to translate such information into clinical applications is often a challenge.
Original languageEnglish (US)
JournalJournal of Systems and Integrative Neuroscience
Issue number1
StatePublished - 2016

Bibliographical note

KAUST Repository Item: Exported on 2020-10-01
Acknowledgements: Author thanks the Fulbright Association , German DAAD Association and the Ministry of Education, Science and Technological Development of the Republic of Serbia for financial support (Project No: 173034).


Dive into the research topics of 'Late phase cell cycle proteins in Alzheimer’s disease: a possible target for therapy?'. Together they form a unique fingerprint.

Cite this